HIV 诊断测试市场，按产品，按测试类型，按最终用户，按地理位置

HIV 诊断测试市场预计 2024 年价值为 44.4 亿美元，预计到 2031 年将达到 82.4 亿美元，2024 年至 2031 年年复合成长率(CAGR) 为 9.2%。

HIV 诊断测试市场占有率 (%)（按地区），2024 年

HIV 诊断测试市场在过去几十年中取得了显着增长，预计未来还将大幅增长。这主要是由于全球受爱滋病毒/爱滋病影响的人数增加。早期发现爱滋病毒感染对于控制疾病传播以及及时开始治疗来提高感染者的生活品质起着至关重要的作用。诊断技术的进步使得快速、简单和即时爱滋病毒检测试剂盒的开发成为可能，从而提高了所有环境下爱滋病毒检测服务的可及性和使用率。

市场动态：

全球爱滋病毒诊断测试市场的成长是由全球爱滋病毒/爱滋病感染率上升所推动的。据世界卫生组织称，2020 年约有 3800 万人感染爱滋病毒。然而，发展中国家对爱滋病毒/爱滋病缺乏认识以及与疾病相关的社会耻辱阻碍了诊断测试的广泛采用。另一方面，不断研发具有更高灵敏度和更短週转时间的新型诊断平台，为市场带来了多种成长机会。

研究的主要特点：

• 该报告对全球爱滋病毒诊断测试市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它阐明了不同细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
• 这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
• 它根据以下参数描述了全球爱滋病毒诊断测试市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
• 该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球爱滋病毒诊断测试市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
• 利害关係人可以透过用于分析全球爱滋病毒诊断测试市场的各种策略矩阵轻鬆做出决策。

目录

第一章：研究目标与假设

• 研究目标
• 假设
• 缩写

第 2 章：市场范围

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map (COM)

第 3 章：市场动态、法规与趋势分析

• 市场动态
  • 司机
  • 限制
  • 市场机会
• 影响分析
• 市场走向
• 最近的发展
• 收购和合作场景
• 技术概览
• 监管场景
• PEST分析

第 4 章：HIV 诊断测试市场 - 冠状病毒 (Covid-19) 大流行的影响

• 整体影响
• 对供需的影响
• COVID-19 对市场的影响

第 5 章：HIV 诊断测试市场，按产品，2019 - 2031 年，（十亿美元）

• 概述
• 检测试剂盒
• 耗材

第 6 章：HIV 诊断测试市场，按测试类型，2019 - 2031 年（十亿美元）

• 概述
• 抗体测试
• 抗原/抗体测试
• 核酸检测

第 7 章：HIV 诊断测试市场，按最终用户划分，2019 - 2031 年（十亿美元）

• 概述
• 医院和诊所
• 诊断实验室
• 家庭护理设置
• 其他的

第 8 章：HIV 诊断测试市场，按地区划分，2019 - 2031 年（十亿美元）

• 介绍
• 北美洲
• 我们
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 拉丁美洲其他地区
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 东协
• 澳洲
• 韩国
• 亚太地区其他地区
• 中东
• 海湾合作委员会
• 以色列
• 中东其他地区
• 非洲
• 北非
• 中非
• 南非

第 9 章：竞争格局

• Abbot
• Bio-Rad Laboratories Inc.
• Hologic Inc.
• Siemens Healthineers
• F. Hoffmann-La Roche Ltd.
• Beckman Coulter Inc.
• OraSure Technologies Inc.
• Becton Dickinson and Company
• Merck KGaA
• Biosynex SA
• Zyomyx Incorporation
• Bristol -Myers Squibb
• Janssen Pharmaceutica NV
• QIAGEN N.V.
• ViiV Healthcare Ltd.

第 10 章：分析师观点

第一章：命运之轮

第 2 章：分析师观点

第 3 章：连贯的机会图

第 11 章：参考文献与研究方法

第 0 章：参考文献

第一章：研究方法

第 2 章：关于我们与销售联络方式

The HIV Diagnostics Test Market is estimated to be valued at USD 4.44 Bn in 2024 and is expected to reach USD 8.24 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.

HIV Diagnostics Test Market Share (%), By Region, 2024

The HIV diagnostics test market has seen significant growth over the past few decades and is expected to grow substantially going forward. This is mainly due to the rise in number of people impacted by HIV/AIDS globally. Early detection of HIV infection plays a vital role in controlling the spread of the disease as well as improves the quality of life of infected individuals with timely treatment initiation. Advancements in diagnostic technologies have enabled development of rapid, simple, and point-of-care HIV testing kits which have improved accessibility and uptake of HIV testing services across all settings.

Market Dynamics:

The global HIV diagnostics test market growth is driven by the rising prevalence of HIV/AIDS infections worldwide. According to WHO, around 38 million people were living with HIV in 2020. Favorable government initiatives and regulations regarding HIV/AIDS diagnosis & management also boost the market growth. However, lack of awareness about HIV/AIDS in developing nations and social stigma associated with the disease hamper widespread adoption of diagnostic tests. On the other hand, ongoing R&D towards development of novel diagnostic platforms with enhanced sensitivity and shorter turn-around-time presents multiple growth opportunities in the market.

Key Features of the Study:

• This report provides in-depth analysis of the global HIV diagnostics test market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global HIV diagnostics test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Abbott, Bio-Rad Laboratories Inc., Hologic Inc., Siemens Healthineers, F. Hoffmann-La Roche Ltd., Beckman Coulter Inc., OraSure Technologies Inc., Becton Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems Inc., Zyomyx Incorporation, Bristol -Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global HIV diagnostics test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HIV diagnostics test market.

Market Segmentation

• Product:
  • Assay Kit
  • Consumables
• Test Type:
  • Antibody Test
  • Antigen/antibody tests
  • Nucleic Acid Test
• End User:
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Homecare Settings
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Abbott
  • Bio-Rad Laboratories Inc.
  • Hologic Inc.
  • Siemens Healthineers
  • Hoffmann-La Roche Ltd.
  • Beckman Coulter Inc.
  • OraSure Technologies Inc.
  • Becton Dickinson and Company
  • Merck KGaA
  • Chembio Diagnostic Systems Inc.
  • Zyomyx Incorporation
  • Bristol -Myers Squibb
  • Janssen Pharmaceutica NV
  • QIAGEN N.V.
  • ViiV Healthcare Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Test Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. HIV Diagnostics Test Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. HIV Diagnostics Test Market, By Product, 2019 - 2031, (USD BN)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Assay Kit
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
• Consumables
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

6. HIV Diagnostics Test Market, By Test Type, 2019 - 2031, (USD BN)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Antibody Test
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
• Antigen/antibody tests
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
• Nucleic Acid Test
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

7. HIV Diagnostics Test Market, By End User, 2019 - 2031, (USD BN)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
• Homecare Settings
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

8. HIV Diagnostics Test Market, By Region, 2019 - 2031, (USD BN)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Regions, 2020-2031
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD BN
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Abbot
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Hologic Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Beckman Coulter Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OraSure Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Becton Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biosynex SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zyomyx Incorporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bristol -Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Janssen Pharmaceutica NV
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• QIAGEN N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ViiV Healthcare Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Analyst View

1. Wheel of Fortune

2. Analyst View

3. Coherent Opportunity Map

11. References and Research Methodology

0. References

1. Research Methodology

2. About us and Sales Contact